Age-related changes of systolic and diastolic function at chronic heart failure in women with overweight and obesity


  • Петро Петрович Бідзіля Zaporozhye state medical university 26 Mayakovsky ave., Zaporozhye, Ukraine, 69035, Ukraine



chronic heart failure, women, systolic, diastolic function, obesity, age-related factor


Women are near 50 % of all patients with chronic heart failure (CHF). Next few years the CHF in women will reach 8 %, and in men only 3 %. In 40 years old the risk of CHF without old myocardium infraction is 1/6 in women and 1/9 in men. The aim of the work was the study of age-related changes of systolic and diastolic function of myocardium at CHF in women with overweight and obesity.

Methods: there were examined 193 women of the different age groups with CHF of I-III functional class on the background of the normal, redundant body mass and abdominal obesity of I-III degree. The indices of systolic and diastolic function of myocardium were assessed by the method of echocardiography. Processing of the received data was carried out by the methods of non-parametric statistics.

Results. There was established that with age in women with overweight and obesity takes place the progression of CHF that is demonstrated by the raise of the functional class of disease, lowering of the systolic function of myocardium, formation and progression of the pulmonary hypertension. There takes place I type of the diastolic dysfunction that is more evident in studied women of the senile age group.

Conclusion: There was demonstrated the negative influence of an ageing on the functional state of myocardium at CHF in women with overweight and obesity

Author Biography

Петро Петрович Бідзіля, Zaporozhye state medical university 26 Mayakovsky ave., Zaporozhye, Ukraine, 69035

Candidate of medical sciences, associate professor

Department of internal diseases 1


Voronkov, L. H. et. al (2013). Rekomendacii po diahnostike I lecheniu khronicheskoi serdechnoi nedostatochnosti (2012) [Guidelines for the diagnosis and treatment of chronic heart failure (2012)]. Ukrainian cardiology journal, 1, 6–44.

Rosamond, W., Flegal, K., Furie, K. et. al (2008). American Heart Association Statistics Committee and Stroke Statistics Subcommittee ”Heart Disease and Stroke Statistics-2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee”. Circulation, 117 (4), 25–146.

Roger, V. L. (2004). Trends in Heart Failure Incidence and Survival in a Community-Based Population. JAMA, 292 (3), 344. doi: 10.1001/jama.292.3.344

Blauwet, L. A., Hayes, S. N., McManus, D., Redberg, R. F., Walsh, M. N. (2007). Low Rate of Sex-Specific Result Reporting in Cardiovascular Trials. Mayo Clinic Proceedings, 82 (2), 166–170. doi: 10.4065/82.2.166

Kannel, W. B. (2000). Incidence and epidemiology of heart failure. Heart Fail Rev, 5 (2), 167–173.

Redberg, R. F., Schiller, N. B. (2004). Gender and valvular surgery. The Journal of Thoracic and Cardiovascular Surgery, 127 (1), 1–3. doi: 10.1016/j.jtcvs.2003.09.022

Lam, C. S. P., Carson, P. E., Anand, I. S., Rector, T. S., Kuskowski, M., Komajda, M. et. al (2012). Sex Differences in Clinical Characteristics and Outcomes in Elderly Patients With Heart Failure and Preserved Ejection Fraction: The Irbesartan in Heart Failure With Preserved Ejection Fraction (I-PRESERVE) Trial. Circulation: Heart Failure, 5 (5), 571–578. doi: 110.1161/circheartfailure.112.970061

Galvao, M., Kalman, J., Demarco, T., Fonarow, G. C., Galvin, C., Ghali, J. K., Moskowitz, R. M. (2006). Gender Differences in In-Hospital Management and Outcomes in Patients With Decompensated Heart Failure: Analysis From the Acute Decompensated Heart Failure National Registry (ADHERE). Journal of Cardiac Failure, 12 (2), 100–107. doi: 10.1016/j.cardfail.2005.09.005

Adams, K. F., Sueta, C. A., Gheorghiade, M., O’Connor, C. M., Schwartz, T. A., Koch, G. G. et. al (1999). Gender Differences in Survival in Advanced Heart Failure : Insights From the FIRST Study. Circulation, 99 (14), 1816–1821. doi: 10.1161/01.cir.99.14.1816

Kenchaiah, S., Evans, J. C., Levy, D., Wilson, P. W. F., Benjamin, E. J., Larson, M. G. et. al (2002). Obesity and the Risk of Heart Failure. New England Journal of Medicine, 347 (5), 305–313. doi: 10.1056/nejmoa020245

Kuriata, O. V., Kushnir, O. S. (2014). Dynamika rivnia aldosteronu u khvorykh na khronochnu sertsevu nedostatnist zi zberezhenoiu fraktsieu vykydu pid vplyvom likuvannia [Dynamics of the level of aldosterone in patients with chronic heart failure with preserved ejection fraction under the influence of treatment]. Medicine of emergency, 2, 57–62.

Çil, H., Bulur, S., Türker, Y., Kaya, A., Alemdar, R., Karabacak, A. et. al (2012). Impact of Body Mass Index on Left Ventricular Diastolic Dysfunction. Echocardiography, 29 (6), 647–651. doi: 10.1111/j.1540-8175.2012.01688.x

Von Haehling, S., Doehner, W., Anker, S. D. (2011). Revisiting the obesity paradox in heart failure: new insights? European Journal of Heart Failure, 13 (2), 130–132. doi: 10.1093/eurjhf/hfq237

Riedinger, M. S., Dracup, K. A., Brecht, M. L. (2000). Predictors of quality of life in women with heart failure. SOLVD Investigators. Studies of Left Ventricular Dysfunction. J. Heart. Lung. Transplant., 19 (6), 598–608.

Domanski, M., Norman, J., Pitt, B., Haigney, M., Hanlon, S., Peyster, E. (2003). Diuretic use, progressive heart failure, and death in patients in the studies of left ventricular dysfunction (SOLVD). Journal of the American College of Cardiology, 42 (4), 705–708. doi: 10.1016/s0735-1097(03)00765-4

Quiñones, M. A., Greenberg, B. H., Kopelen, H. A., Koilpillai, C., Limacher, M. C., Shindler, D. M. et. al (2000). Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy. Studies of Left Ventricular Dysfunction. Journal of the American College of Cardiology, 35 (5), 1237–1244. doi: 10.1016/s0735-1097(00)00511-8